Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction

Christoph Edlinger; Bernhard Wernly; Michael Leisch; J Kammler; A Kypta; S Eder; Thomas Wuppinger; T Moesenlechner; Mathias Ausserwinkler; C Jung; Uta Hoppe; Michael Lichtenauer

Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction

Christoph Edlinger, Bernhard Wernly, Michael Leisch, J Kammler, A Kypta, S Eder, Thomas Wuppinger, T Moesenlechner, Mathias Ausserwinkler, C Jung, Uta Hoppe, Michael Lichtenauer

Universitätsklinik für Innere Medizin 2 - Kardiologie, Internistische Intensivmedizin und Notaufnahme
Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	515-516
Fachzeitschrift	EUROPEAN HEART JOURNAL
Jahrgang	37
Publikationsstatus	Veröffentlicht - 2016
Veranstaltung	Congress of the European-Society-of-Cardiology (ESC) - Rome, ITALY Dauer: 27 Aug. 2016 → 31 Aug. 2016

Dieses zitieren

Edlinger, C., Wernly, B., Leisch, M., Kammler, J., Kypta, A., Eder, S., Wuppinger, T., Moesenlechner, T., Ausserwinkler, M., Jung, C., Hoppe, U., & Lichtenauer, M. (2016). Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction. EUROPEAN HEART JOURNAL , 37, 515-516.

Edlinger, Christoph ; Wernly, Bernhard ; Leisch, Michael et al. / Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction. in: EUROPEAN HEART JOURNAL 2016 ; Jahrgang 37. S. 515-516.

@article{5fff61a671f04076884001e1f81887f6,

title = "Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction",

author = "Christoph Edlinger and Bernhard Wernly and Michael Leisch and J Kammler and A Kypta and S Eder and Thomas Wuppinger and T Moesenlechner and Mathias Ausserwinkler and C Jung and Uta Hoppe and Michael Lichtenauer",

year = "2016",

language = "English",

volume = "37",

pages = "515--516",

journal = "EUROPEAN HEART JOURNAL ",

issn = "0195-668X",

publisher = "Oxford Univ Press",

note = "Congress of the European-Society-of-Cardiology (ESC) ; Conference date: 27-08-2016 Through 31-08-2016",

}

Edlinger, C , Wernly, B , Leisch, M, Kammler, J, Kypta, A, Eder, S, Wuppinger, T, Moesenlechner, T, Ausserwinkler, M, Jung, C, Hoppe, U & Lichtenauer, M 2016, 'Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction', EUROPEAN HEART JOURNAL , Jg. 37, S. 515-516.

Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction. / Edlinger, Christoph ; Wernly, Bernhard ; Leisch, Michael et al.
in: EUROPEAN HEART JOURNAL , Jahrgang 37, 2016, S. 515-516.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction

AU - Edlinger, Christoph

AU - Wernly, Bernhard

AU - Leisch, Michael

AU - Kammler, J

AU - Kypta, A

AU - Eder, S

AU - Wuppinger, Thomas

AU - Moesenlechner, T

AU - Ausserwinkler, Mathias

AU - Jung, C

AU - Hoppe, Uta

AU - Lichtenauer, Michael

PY - 2016

Y1 - 2016

M3 - Abstract (Journal)

SN - 0195-668X

VL - 37

SP - 515

EP - 516

JO - EUROPEAN HEART JOURNAL

JF - EUROPEAN HEART JOURNAL

T2 - Congress of the European-Society-of-Cardiology (ESC)

Y2 - 27 August 2016 through 31 August 2016

ER -

Edlinger C , Wernly B , Leisch M, Kammler J, Kypta A, Eder S et al. Analysis of ambient influences affecting Interleukin-6 as a paracrine mediator in clinical trials of stem cell therapy for myocardial infarction. EUROPEAN HEART JOURNAL . 2016;37:515-516.